Ainos, Inc. (NASDAQ:AIMD) Short Interest Up 1,098.7% in March

Ainos, Inc. (NASDAQ:AIMDGet Free Report) was the recipient of a significant growth in short interest in March. As of March 15th, there was short interest totalling 91,100 shares, a growth of 1,098.7% from the February 29th total of 7,600 shares. Based on an average daily trading volume, of 1,830,000 shares, the short-interest ratio is currently 0.0 days. Currently, 5.6% of the shares of the stock are short sold.

Ainos Price Performance

Shares of NASDAQ:AIMD opened at $1.18 on Thursday. The firm has a market cap of $7.02 million, a PE ratio of -0.46 and a beta of 1.44. The firm’s fifty day moving average is $1.10 and its 200-day moving average is $2.25. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.72 and a current ratio of 1.85. Ainos has a 52 week low of $0.79 and a 52 week high of $6.10.

About Ainos

(Get Free Report)

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.

Read More

Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.